Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CCAR-066 by Janssen Biotech for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
CCAR-066 is under clinical development by Janssen Biotech and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...
CCAR-066 by Janssen Biotech for Follicular Lymphoma: Likelihood of Approval
CCAR-066 is under clinical development by Janssen Biotech and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
CCAR-066 by Janssen Biotech for Marginal Zone B-cell Lymphoma: Likelihood of Approval
CCAR-066 is under clinical development by Janssen Biotech and currently in Phase I for Marginal Zone B-cell Lymphoma. According to...